Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Breast Cancer Reports
Erschienen in: Current Breast Cancer Reports 2/2013

01.06.2013 | Local-Regional Evaluation and Therapy (KK Hunt, Section Editor)

Best-Practice Guidelines in Assessment, Risk Reduction, Management, and Surveillance for Post-Breast Cancer Lymphedema

verfasst von: Jane M. Armer, Jennifer M. Hulett, Michael Bernas, Pam Ostby, Bob R. Stewart, Janice N. Cormier

Erschienen in: Current Breast Cancer Reports | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer-related lymphedema (LE) is a progressive, chronic disease that affects millions of cancer survivors and primarily results from surgical lymphatic vessel and/or node removal and radiation therapy. Patient support and education in the importance of early detection is essential in helping health care providers detect lymphedema early, when there is the best chance of preventing progression. Improved imaging and surgical techniques have reduced the incidence of LE; however, effective risk-reduction and treatment have historically lacked the level of evidence necessary to standardize effective treatment. The purpose of this article is to report an extensive review of literature, including highlighted multidisciplinary studies within the past 3 years, in order to update best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema.
Literatur
1.
2.
Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann N Y Acad Sci. 2008;1131:147–54.PubMedCrossRef
3.
• Armer JM, Stewart BR. Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology. 2010;43:118–27. This study followed survivors’ limb volume change from pre-surgery through 57 months post-surgery using the four most commonly cited diagnostic criteria (2 cm circumferential change, 200 mL perometry LVC, 10 % perometry LVC, and signs/symptoms) and found that the 2 cm criterion is the most liberal definition of LE, followed by the 200 mL perometry criterion.PubMed
4.
Földi M, Földi E, Kubik S. In Textbook of lymphology: for physicians and lymphedema therapists. Urban and Fisher: San Francisco, CA; 2003.
5.
Hayes S, Di Sipio T, Rye S, et al. Prevalence and prognostic significance of secondary lymphedema following breast cancer. Lymphat Res Biol. 2011;9(3):135–41.PubMedCrossRef
6.
•• Bernas M, Askew R, Armer J, Cormier J. Lymphedema: how do we diagnose and reduce the risk of this dreaded complication of breast cancer treatment? Curr Breast Cancer Rep. 2010;2(1):53–8. This article highlights current practices in LE risk-reduction practices and methods of diagnosis and assessment. Recommendations include identifying patients with early swelling for referral to LE treatment specialists.CrossRef
7.
Mahamaneerat WK, Shyu C-R, Stewart BR, Armer JM. Breast cancer treatment, BMI, post-op swelling/lymphoedema. J Lymphoedema. 2008;3(2):38–44.PubMed
8.
•• Armer JM, Stewart BR, Wanchai A, et al. Rehabilitation concepts among aging survivors living with and at risk for lymphedema: a framework for assessment, enhancing strengths, and minimizing vulnerability. Top Geriatr Rehabil. 2012;28(4):260–8. This article discusses the complexity of issues affecting rehabilitative outcomes in detection and management of post-treatment LE in an aging breast cancer survivor population. With improved cancer detection and treatment, the number of older cancer survivors is predicted to increase, making imperative attention to a survivorship rehabilitation-focused program of surveillance.
9.
Bellury LM, Ellington L, Beck SL, et al. Elderly cancer survivorship: an integrative review and conceptual framework. Eur J Oncol Nurs. 2011;15:233–42.PubMedCrossRef
10.
Modi S, Stanton AWB, Mortimer PS, Levick JR. Clinical assessment of human lymph flow using removal rate constants of interstitial macromolecules: a critical review of lymphoscintigraphy. Lymphat Res Biol. 2007;5(3):183–202.PubMedCrossRef
11.
Witte CL. Advances in imaging of lymph flow disorders. RadioGraphics. 2000;20:1697–719.PubMed
12.
Adams KE, Rasmussen JC, Darne C, et al. Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema. Biomed Opt Express. 2010;1:114–25.PubMedCrossRef
13.
Unno N, Nishiyama M, Suzuki M, et al. Quantitative lymph imaging for assessment of lymph function using indocyanine green fluorescence lymphography. Eur J Endovasc Surg. 2008;36(2):230–6.CrossRef
14.
Rasmussen JC, Tan IC, Marshall MV, et al. Lymphatic imaging in humans with near-infrared fluorescence. Curr Opin Biotechnol. 2009;20(1):74–82.PubMedCrossRef
15.
Rasmussen JC, Kwon S, Sevick-Muraca EM, Cormier JN. The role of lymphatics in cancer as assessed by near-infrared fluorescence imaging. Ann Biomed Eng. 2012;40(2):408–21.PubMedCrossRef
16.
Giacalone G, Belgrado JP, Bourgeois P, et al. A new dynamic imaging tool to study lymphoedema and associated treatments. Eur J Lymphology. 2011;22(62):10–4.
17.
Liu NF, Lu Q, Jiang ZH, et al. Anatomic and functional evaluation of the lymphatics and lymph nodes in diagnosis of lymphatic circulation disorders with contrast magnetic resonance lymphangiography. J Vasc Surg. 2009;49(4):980–7.PubMedCrossRef
18.
Armer JM. The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Investig. 2005;23(1):76–83.CrossRef
19.
Sagen A, Karesen R, Risberg MA. Physical activity for the affected limb and arm lymphedema after breast cancer surgery. A prospective, randomized controlled trial with two years follow-up. Acta Oncol. 2009;48(8):1102–10.PubMedCrossRef
20.
Mayrovitz HN. Limb volume estimates based on limb elliptical vs. circular cross section models. Lymphology. 2003;36(3):140–3.PubMed
21.
Stanton AW, Northfield JW, Holroyd B, et al. Validation of an optoelectronic limb volumeter (perometer). Lymphology. 1997;30(2):77–97.PubMed
22.
Armer JM, Stewart BR, Shook RP. 30-month post-breast cancer treatment lymphoedema. J Lymphoedema. 2009;4(1):14–8.PubMed
23.
Moseley A, Piller N. Reliability of bioimpedance spectroscopy and tonometry after breast conserving cancer treatment. Lymphat Res Biol. 2008;6(2):85–7.PubMedCrossRef
24.
Smoot BJ, Wong JF, Dodd MJ. Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curve. Arch Phys Med Rehabil. 2011;92(4):603–10.PubMedCrossRef
25.
Cornish BH, Chapman M, Hirst C, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. 2001;34(1):2–11.PubMed
26.
Mayrovitz HN, Brown-Cross D, Mayrovitz BL, Golla AH. Lymphedema: role of truncal clearance as a therapy component. Home Health Care Manag Pract. 2009;21(5):325–37.CrossRef
27.
Bagheri S, Ohlin K, Olsson G, Brorson H. Tissue tonometry before and after liposuction of arm lymphedema following breast cancer. Lymphat Res Biol. 2005;3(2):66–80.PubMedCrossRef
28.
International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2009 consensus document of the International Society of Lymphology. Lymphology. 2009;42:51–60.
29.
Shah C, Arthur D, Riutta J, et al. Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment aids, treatment paradigms, and risk reduction. Breast J. 2012;18(4):357–61.PubMedCrossRef
30.
Sanghani M, Balk EM, Cady B. Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis. Cancer. 2009;115(8):1613–20.PubMedCrossRef
31.
Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.PubMedCrossRef
32.
Boneti C, Korourian S, Bland K, et al. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg. 2008;206(5):1038–42. discussion 42–44.PubMedCrossRef
33.
Klimberg VS. A new concept toward the prevention of lymphedema: axillary reverse mapping. J Surg Oncol. 2008;97(7):563–4.PubMedCrossRef
34.
Boccardo FM, Ansaldi F, Bellini C, et al. Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer. Lymphology. 2009;42(1):1–9.PubMed
35.
Boccardo F, Casabona F, De Cian F, et al. Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol. 2009;16(3):703–8.PubMedCrossRef
36.
Box RC, Reul-Hirche HM, Bullock-Saxton JE, Furnival CM. Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema. Breast Cancer Res Treat. 2002;75(1):51–64.PubMedCrossRef
37.
Stout Gergich NL, Pfalzer LA, Mcgarvey C, et al. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809–19.PubMedCrossRef
38.
Torres Lacomba M, Yuste Sanchez MJ, Zapico Goni A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. In BMJ. 2010, 340: b5396.
39.
Hayes SC, Reul-Hirche H, Turner J. Exercise and secondary lymphedema: safety, potential benefits, and research issues. Med Sci Sports Exerc. 2009;41(3):483–9.PubMedCrossRef
40.
Schmitz KH. Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors. Exerc Sport Sci Rev. 2010;38(1):17–24.PubMedCrossRef
41.
•• Lasinski BB, Mckillip Thrift K, Squire D, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM&R. 2012;4(8):580–601. In a review of 26 articles published between 2004 and 2011, complete decongestive therapy, as a combination of intervention procedures, was found to reduce limb swelling associated with lymphedema, as did the individual components manual lymphatic drainage and compression bandaging.CrossRef
42.
Moseley AM, Sherrington C, Elkins MR, et al. Indexing of randomised controlled trials of physiotherapy interventions: a comparison of AMED, CENTRAL, CINAHL, EMBASE, hooked on evidence, PEDro, PsycINFO and PubMed. Physiotherapy. 2009;95(3):151–6.PubMedCrossRef
43.
44.
Lymphoedema Framework. Best practice for the management of lymphoedema. London: MEP Ltd; 2006.
45.
• Ridner SH, Fu MR, Wanchai A, et al. Self-management of lymphedema: a systematic review of the literature from 2004 to 2011. Nurs Res. 2012;61(4):291–9. Combined decongestive therapy and full body exercise as self-management actions were given a “likely to be effective” rating using the Oncology Nursing Society (ONS) putting evidence into practice (PEP) criteria.PubMedCrossRef
46.
Schmitz KH, Troxel AB, Cheville A, et al. Physical activity and lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivors. Contemp Clin Trials. 2009;30(3):233–45.PubMedCrossRef
47.
Morello E, Sandri R, Monfardini S. Enough rehabilitation for our elderly cancer patients? Eur J Cancer. 2008;44(16):2338–9.PubMedCrossRef
48.
49.
50.
• Beck M, Wanchai A, Stewart BR, et al. Palliative care for cancer-related lymphedema: a systematic review. J Palliat Med. 2012;15(7):821–7. This systematic review of palliative care LE management concluded that CDT, MLD, and compression bandaging are categorized as “effectiveness not established,” but note that no adverse findings were reported. On the basis of these findings, CDT, MLD, and compression bandaging offer a potential benefit to LE symptom control and improved quality of life for LE patients receiving palliative care.PubMedCrossRef
51.
52.
•• Cormier JN, Rourke L, Crosby M, et al. The surgical treatment of lymphedema: a systematic review of the contemporary literature (2004–2010). Ann Surg Oncol. 2012;19(2):642–51. Surgical techniques have been shown to benefit some patients with LE symptoms, but not without continued use of CDT and compression for most patients in the study. Studies with non-surgical vs. surgical intervention are needed to evaluate efficacy and consideration of risk. Conservative therapy remains the first-line treatment. Risks of surgery must be weighed against benefits in survivor outcomes; compression garments must still be worn long-term post-operatively.PubMedCrossRef
53.
Moseley AL, Carati CJ, Piller NB. A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Ann Oncol. 2007;18:639–46.PubMedCrossRef
54.
Rinehart-Ayres M, Fish K, Lapp K, Brown CN. Use of compression pumps for treatment of upper extremity lymphedema following treatment for breast cancer: a systematic review. Rehab Oncol. 2010;28:10–8.
55.
Feldman JL, Stout NL, Wanchai A, et al. Intermittent pneumatic compression therapy: a systematic review. Lymphology. 2012;45(1):13–25.PubMed
56.
• Schmitz KH, Speck RM, Rye SA, et al. Prevalence of breast cancer treatment sequelae over 6 years of follow-up: the pulling through study. Cancer. 2012;118(8 Suppl):2217–25. At six years post-diagnosis, most survivors experience one or more late effects of breast cancer treatment amenable to rehabilitative intervention. Data support a multidisciplinary prospective surveillance approach in the management and treatment of adverse effects of breast cancer treatment.PubMedCrossRef
57.
•• Kwan ML, Cohn JC, Armer JM, et al. Exercise in patients with lymphedema: a systematic review of the contemporary literature. J Cancer Surviv. 2011;5(4):320–36. This systematic review of the literature concludes that supervised slow, progressive resistance exercise programs, under proper supervision, are safe for breast cancer survivors at risk of secondary LE. Combination aerobic and resistance programs seem safe, but require more rigorous study.PubMedCrossRef
58.
• Schmitz KH, Ahmed RL, Troxel AB, et al. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA. 2010;304(24):2699–705. Among breast cancer survivors at risk of LE, exercise in a supervised progressive weight lifting program did not increase the incidence of LE compared with no exercise.PubMedCrossRef
59.
• Schmitz KH, Ahmed RL, Troxel A, et al. Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med. 2009;361(7):664–73. The PALS trial showed that among breast-cancer survivors with LE supervised slowly progressive weight lifting had no significant effect on limb edema. Those exercising experienced reduced incidence of LE exacerbation, reduced symptoms, and increased strength.PubMedCrossRef
60.
Ahmed RL, Schmitz KH, Prizment AE, Folsom AR. Risk factors for lymphedema in breast cancer survivors, the Iowa Women’s Health Study. Breast Cancer Res Treat. 2011;130(3):981–91.PubMedCrossRef
61.
Kilbreath SL, Refshauge KM, Beith JM, et al. Progressive resistance training and stretching following surgery for breast cancer: study protocol for a randomised controlled trial. BMC Cancer. 2006;6:273.PubMedCrossRef
62.
Irdesel J, Kahraman CS. Effectiveness of exercise and compression garments in the treatment of breast cancer related lymphedema. Turk J Phys Med Rehabil. 2007;53(1):16–21.
63.
Sander AP. A safe and effective upper extremity resistive exercise program for woman post breast cancer treatment. Rehab Oncol. 2008;26(3):3–10.
64.
Courneya KS, Segal RJ, Mackey JR, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007;25(28):4396–404.PubMedCrossRef
65.
Portela ALM, Santaella CLC, Gomez CC, Burch A. Feasibility of an exercise program for Puerto Rican women who are breast cancer survivors. Rehab Oncol. 2008;26(2):20–31.
66.
Kilbreath S, Refshauge K, Beith J, Lee M. Resistance and stretching shoulder exercises early following axillary surgery for breast cancer. Rehab Oncol. 2006;24(2):9–14.
67.
Schmitz KH, Stout NL, Andrews K, et al. Prospective evaluation of physical rehabilitation needs in breast cancer survivors: a call to action. Cancer. 2012;118(8 Suppl):2187–90.PubMedCrossRef
68.
Wanchai A, Armer JM, Stewart BR. Performance care practices in complementary and alternative medicine by Thai breast cancer survivors: an ethnonursing study. Nurs Heal Sci. 2012;14(3):339–44.CrossRef
69.
Finnane A, Liu Y, Battistutta D, et al. Lymphedema after breast or gynecological cancer: use and effectiveness of mainstream and complementary therapies. J Altern Complement Med. 2011;17(9):867–9.PubMedCrossRef
70.
Matchim Y, Armer JM, Stewart BR. Effects of mindfulness-based stress reduction (MBSR) on health among breast cancer survivors. West J Nurs Res. 2011;33(8):996–1016.PubMedCrossRef
71.
Tidhar D, Katz-Leurer M. Aqua lymphatic therapy in women who suffer from breast cancer treatment-related lymphedema: a randomized controlled study. Support Care Cancer. 2010;18(3):383–92.PubMedCrossRef
72.
Arinaga Y. Holistic management of lymphoedema in Japan: two contrasting cases. J Lymphoedema. 2012;7(2):40–2.
73.
Cassileth BR, Van Zee KJ, Chan Y, et al. A safety and efficacy pilot study of acupuncture for the treatment of chronic lymphoedema. Acupunct Med. 2011;29(3):170–2.PubMedCrossRef
74.
De Valois BA, Young TE, Melsome E. Assessing the feasibility of using acupuncture and moxibustion to improve quality of life for cancer survivors with upper body lymphoedema. Eur J Oncol Nurs. 2012;16(3):301–9.PubMedCrossRef
75.
Douglass J, Immink M, Piller N, Ullah S. Yoga for women with breast cancer-related lymphoedema: a preliminary 6-month study. J Lymphoedema. 2012;7(2):30–8.
76.
Disa JJ, Petrek J. Rehabilitation after treatment for cancer of the breast. In: Devita Jr VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. 6th ed. Philadelphia: Lippincott, Williams, & Wilkins; 2001. p. 1717–26.
77.
Moffatt CJ, Franks PJ, Doherty DC, et al. Lymphoedema: an underestimated health problem. QJM. 2003;96(10):731–8.PubMedCrossRef
78.
Shih YC, Xu Y, Cormier JN, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27(12):2007–14.PubMedCrossRef
79.
Witek-Janusek L, Gabram S, Mathews HL. Psychologic stress, reduced nk cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy. Psychoneuroendocrinology. 2007;32(1):22–35.PubMedCrossRef
80.
81.
Fu MR, Ridner SH, Hu SH, et al. Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psycho-Oncology. 2012. doi:10.​1002/​pon.​3201. first published online: 9 Oct 2012.
82.
Cormier JN, Ross MI, Gershenwald JE, et al. Prospective assessment of the reliability, validity, and sensitivity to change of the functional assessment of cancer therapy—melanoma questionnaire. Cancer. 2008;112(10):2249–57.PubMedCrossRef
83.
Johansson K, Branje E. Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis. Acta Oncol. 2010;49:166–73.PubMedCrossRef
84.
•• Hayes SC, Johansson K, Stout NL, et al. Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer. 2012;118(8 Suppl):2237–49. This paper reviewed the incidence of upper-body morbidity (arm and breast symptoms, impairments, and lymphedema), methods of diagnosis, prevention and treatment strategies, and the evidence for integration of prospective surveillance for upper-body morbidity within standard clinical care of women with breast cancer. There is evidence in support of integrating regular surveillance for upper-body morbidity into the routine clinical care provided to women with breast cancer, with early diagnosis potentially contributing to more effective management and prevention of progression of these conditions.PubMedCrossRef
85.
•• Stout NL, Binkley JM, Schmitz KH, et al. A prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012;118(8 Suppl):2191–200. The objectives of a prospective surveillance model include: promotion of surveillance of common physical and functional limitations associated with breast-cancer treatment; education for early identification of physical impairment and functional limitation; referral for rehabilitation and exercise intervention when physical limitations are identified; and promotion and support of physical activity, exercise, nutrition, and weight-management behavior throughout survival.PubMedCrossRef
86.
• Binkley JM, Harris SR, Levangie PK, et al. Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer. 2012;118(8 Suppl):2207–16. The prospective surveillance model of rehabilitation serves the needs of breast cancer survivors by providing education and information about treatment side effects, reducing the incidence and burden of side effects through early identification and treatment, and enhancing access to timely rehabilitation. Integration of exercise into the model benefits patients at every phase of survivorship. Application of the model can meet the needs of survivors for information, guidance, and intervention—thus addressing, and potentially improving, overall quality of life for individuals treated for breast cancer.PubMedCrossRef
87.
Reneker J, Armer J, Stewart B, Shyu CR. Development of a minimum data set to assist in international collaborative lymphedema studies. In 23rd International Congress of Lymphology proceedings. Lymphology (supp) 2013 in press.
88.
89.
•• Bernas M. Assessment and risk reduction in lymphedema. Semin Oncol Nurs. 2013;29(1):12–9. Risk-reduction strategies and methods for assessment, diagnosis, and treatment of lymphedema are a major focus in oncology. Operative and physical methods to reduce the risk of lymphedema and an emphasis on early detection have led to promising results post-breast cancer surgery and/or radiation therapy. Standardization of reproducible methods utilizing currently available and reliable tools are necessary to determine the most effective means to care for patients at risk of development of lymphedema.PubMedCrossRef
Metadaten
Titel
Best-Practice Guidelines in Assessment, Risk Reduction, Management, and Surveillance for Post-Breast Cancer Lymphedema
verfasst von
Jane M. Armer
Jennifer M. Hulett
Michael Bernas
Pam Ostby
Bob R. Stewart
Janice N. Cormier
Publikationsdatum
01.06.2013
Verlag
Current Science Inc.
Erschienen in
Current Breast Cancer Reports / Ausgabe 2/2013
Print ISSN: 1943-4588
Elektronische ISSN: 1943-4596
DOI
https://doi.org/10.1007/s12609-013-0105-0

Weitere Artikel der Ausgabe 2/2013

Current Breast Cancer Reports 2/2013 Zur Ausgabe

Local-Regional Evaluation and Therapy (KK Hunt, Section Editor)

New Treatment Paradigms for Patients with Ductal Carcinoma In Situ

Local-Regional Evaluation and Therapy (KK Hunt, Section Editor)

State of the Art in Imaging and Chemoprevention for High-Risk Patients

Local-Regional Evaluation and Therapy (KK Hunt, Section Editor)

Techniques and Outcomes of Nipple Sparing Mastectomy in the Surgical Management of Breast Cancer

Local-Regional Evaluation and Therapy (KK Hunt, Section Editor)

Is Partial Breast Irradiation a Safe and Effective Treatment Approach for Women with Early-Stage Breast Cancer?

Local-Regional Evaluation and Therapy (KK Hunt, Section Editor)

Individualizing Axillary Management in Breast Cancer Treatment

Local-Regional Evaluation and Therapy (KK Hunt, Section Editor)

Should Local Therapy for Invasive Breast Cancer Be Customized on the Basis of Subtype?

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 | NSCLC | Nachrichten

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

24.04.2024 | DGIM 2024 | Nachrichten

Bei Senioren mit Prostatakarzinom auf Anämie achten!

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

ICI-Therapie in der Schwangerschaft wird gut toleriert
weitere anzeigen

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen